Hostname: page-component-54dcc4c588-rz4zl Total loading time: 0 Render date: 2025-10-12T14:44:06.606Z Has data issue: false hasContentIssue false
  • English
  • Français

Utility of cardiac MRI in paediatric myocarditis

Published online by Cambridge University Press:  14 December 2017

Alice Hales-Kharazmi ,
Nina Hirsch ,
Michael Kelleman ,
Timothy Slesnick  and
Shriprasad R. Deshpande
Alice Hales-Kharazmi
Affiliation:
Department of Pediatrics, Division of Cardiology, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States of America
Nina Hirsch
Affiliation:
Philadelphia College of Osteopathic Medicine – Georgia Campus, Atlanta, Georgia, United States of America Rollins School of Public Health, Emory University
Michael Kelleman
Affiliation:
Department of Pediatrics, Division of Cardiology, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States of America
Timothy Slesnick
Affiliation:
Department of Pediatrics, Division of Cardiology, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States of America
Shriprasad R. Deshpande*
Affiliation:
Department of Pediatrics, Division of Cardiology, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States of America
*
Correspondence to: S. R. Deshpande, Assistant Professor, Department of Pediatrics, Division of Pediatric Cardiology, Children’s Healthcare of Atlanta, Emory University School of Medicine, 1405 Clifton Road NE, Atlanta, GA, 30322-1101, United States of America. Tel: 404-256-2593; Fax: 770-488-9480; E-mail: deshpandes@kidsheart.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

The diagnostic role of cardiac MRI in myocarditis is evolving, however with extremely limited data in paediatrics. The goal of this study was to assess the utility of cardiac MRI in paediatric myocarditis and present a new prognostic score for risk stratification.

Method

The present study is a retrospective investigation of children with a clinical diagnosis of myocarditis, including analysis of demographics, clinical presentation, diagnostic studies, including cardiac MRI, and outcomes.

Results

A total of 44 patients met the inclusion criteria, of whom 20 had undergone cardiac MRI. Patients who underwent cardiac MRI were older (median 15.6 versus 11.1 years, p=0.004), had a shorter length of hospital stay (median 4.0 versus 12.5 days, p=0.004), had overall less-severe illness at presentation as evidenced by a higher left-ventricular ejection fraction on echocardiography, had lower peak brain-type natriuretic peptide, were less likely to require advanced mechanical support, and were less likely to experience cardiac death or transplant. In patients who had undergone cardiac MRI, the most common findings were increased early gadolinium enhancement (n=9) or late gadolinium enhancement (n=9). Cardiac MRI findings did not predict a worse outcome. Independent predictors of the need for heart-failure medications at 1-year follow-up included inotrope requirement, extracorporeal membrane oxygenator requirement, and antiarrhythmic requirement at presentation (p<0.05).

Conclusion

In paediatric myocarditis, cardiac MRI is not used uniformly, has a low yield, and does not predict worse outcomes. Future research should evaluate clinical decision-making and the cost–benefit analysis of cardiac MRI in the diagnosis of paediatric myocarditis.

Keywords

Myocarditiscardiac MRIpaediatric heart failurebiomarkersheart transplant

Information

Type
Original Articles
Information
Cardiology in the Young , Volume 28 , Issue 3 , March 2018 , pp. 377 - 385
Check for updates
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Drory, Y, Turetz, Y, Hiss, Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991; 68: 1388–1392.Google Scholar
2. Ghelani, SJ, Spaeder, MC, Pastor, W, Spurney, CF, Klugman, D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes 2012; 5: 622–627.CrossRefGoogle ScholarPubMed
3. Aretz, H. Myocarditis: the Dallas criteria. Human Pathol 1987; 18: 619–624.CrossRefGoogle ScholarPubMed
4. Mason, J, O’Connell, JB. Clinical merit of endomyocardial biopsy. Circulation 1989; 79: 971–980.CrossRefGoogle ScholarPubMed
5. Canter, CE, Simpson, KP. Diagnosis and treatment of myocarditis in children in the current era. Circulation 2014; 129: 115–128.CrossRefGoogle ScholarPubMed
6. Gagliardi, MG, Bevilacqua, M, Di Renzi, P, Picardo, S, Passariello, R, Marcelletti, C. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 1991; 68: 1089–1091.Google Scholar
7. Friedrich, MG, Sechtem, U, Schulz-Menger, J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009; 53: 1475–1487.CrossRefGoogle ScholarPubMed
8. Levine, MC, Klugman, D, Teach, SJ. Update on myocarditis in children. Curr Opin Pediatr 2010; 22: 278–283.CrossRefGoogle ScholarPubMed
9. Sachdeva, S, Song, X, Dham, N, Heath, DM, DeBiasi, RL. Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol 2015; 115: 499–504.Google Scholar
10. Schumm, J, Greulich, S, Wagner, A, et al. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson 2014; 16: 14.Google Scholar
11. Sanguineti, F, Garot, P, Mana, M, et al. Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis. J Cardiovasc Magn Reson 2015; 17: 78.Google Scholar
12. Banka, P, Robinson, JD, Uppu, SC, et al. Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study. J Cardiovasc Magn Reson 2015; 17: 96.CrossRefGoogle ScholarPubMed
13. Mahrholdt, H, Wagner, A, Deluigi, CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006; 114: 1581–1590.Google Scholar
14. Grun, S, Schumm, J, Greulich, S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012; 59: 1604–1615.Google Scholar
15. Ferreira, VM, Piechnik, SK, Dall’Armellina, E, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013; 6: 1048–1058.Google Scholar
16. Bohnen, S, Radunski, UK, Lund, GK, et al. Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circ Cardiovasc Imaging 2015; 8: e003073.Google Scholar
17. Spieker, M, Haberkorn, S, Gastl, M, et al. Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis. J Cardiovasc Magn Reson 2017; 19: 38.Google Scholar